Abnormal interaction of Rlip with mutant APP/Abeta and phosphorylated tau reduces wild-type Rlip levels and disrupt Rlip function in Alzheimer's disease

Biochim Biophys Acta Mol Basis Dis. 2024 Jan;1870(1):166858. doi: 10.1016/j.bbadis.2023.166858. Epub 2023 Aug 25.

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease that affects a large proportion of the aging population. RalBP1 (Rlip) is a stress-activated protein, that plays an important role in aging and neurodegenerative diseases such as Alzheimer's disease. Mutant APP and mutant Tau interact with the Rlip protein which leads to decreased wild-type Rlip levels and disrupt Rlip function in Alzheimer's disease. Rlip is a promising new target for aging, Alzheimer's disease, and other neurological diseases.

Keywords: Alzheimer's disease; Mitochondrial dysfunction; Oxidative stress; Rlip protein.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease* / genetics
  • Alzheimer Disease* / metabolism
  • Humans
  • Neurodegenerative Diseases*

Substances

  • RALBP1 protein, human
  • MAPT protein, human
  • APP protein, human